Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases
NCT07030881Recruiting
- Sponsor
- First Affiliated Hospital of Ningbo University
- Start
- Jun 2025
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by First Affiliated Hospital of Ningbo University. Primary endpoint: Incidence of Moderate-to-Severe Acute Exacerbations at 3 months. Started Jun 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07030881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07030881.